Carbonylbisphosphonate and (diazomethylene)bisphosphonate analogues of AZT 5′-diphosphate

Bioorganic Chemistry

Volumn 30, Issue 6, 2002, Pages 383-395

  McKenna, Charles E ^a   Kashemirov, Boris A ^a   Rozé, Christian N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

(Diazomethylene)bisphosphonate; AZT; Carbonylbisphosphonate; Nucleotide analogue

Indexed keywords

3' AZIDO 3' DEOXYTHYMIDINE 5' (DIAZOMETHYLENE)BIPHOSPHONATE; 3' AZIDO 3' DEOXYTHYMIDINE 5' CARBONYLBISPHOSPHONATE; DISODIUM DIMETHYL(DIAZOMETHYLENE)BISPHOSPHONATE; ENZYME INHIBITOR; MAGNESIUM ION; NUCLEOTIDE DERIVATIVE; SODIUM TRIMETHYL(DIAZOMETHYLENE)BISPHOSPHONATE; TRIMETHYL 3' AZIDO 3' DEOXYTHYMIDINE 5' (DIAZOMETHYLENE)BISPHOSPHONATE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHROMATOPHORE; DRUG SYNTHESIS; ENZYME INHIBITION; MASS SPECTROMETRY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0036914840     PISSN: 00452068     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0045-2068(02)00521-7     Document Type: Article

References (51)

1. B.A. Kashemirov, C.N. Rozé, C.E. McKenna, XVth Internat. Conf. Phos. Chem., July 28-Aug. 2, Sendai, Japan, PA017, (2001).
2. Kashemirov B.A., Rozé C.N., McKenna C.E. Phosphorus Sulfur Silicon Relat. Elem. 177:2002;2275-2276.
3. Davisson V.J., Davis D.R., Dixit V.M., Poulter C.D. J. Org. Chem. 52:1987;1794-1801.
4. McLennan A.G., Taylor G.E., Prescott M., Blackburn G.M. Biochemistry. 28:1989;3868-3875.
5. Lesiak K., Watanabe K.A., Majumdar A., Seidman M., Vanderveen K., Goldstein B.M., Pankiewicz K.W. J. Med. Chem. 40:1997;2533-2538.
6. Blackburn G.M., Kent D.E., Kolkmann F. J. Chem. Soc. Perkin Trans. 1:1984;1119-1125.
7. Balzarini J., Herdewijn P., Pauwels R., Broder S., De Clercq E. Biochem. Pharmacol. 37:1988;2395-2403.
8. Blackburn G.M., Langston S.P. Tetrahedron Lett. 32:1991;6425-6428.
9. Guranowski A., Starzynska E., Gzik L., Langston S.P., Brown P., Blackburn G.M. Nucleosides Nucleotides. 14:1995;731-734.
10. Hamilton C.J., Roberts S.M., Shipitsin A. Chem. Commun. (Cambridge). 1998;1087-1088.
11. McKenna C.E., Shen P.D. J. Org. Chem. 46:1981;4573-4576.
12. Burton D.J., Pietrzyk D.J., Ishihara T., Fonong T., Flynn R.M. J. Fluorine Chem. 20:1982;617-626.
13. McKenna C.E., Leswara N.D., Shen P.D. Fed. Proc. 41:1982;860.
14. McKenna C.E., Khawli L.A. Phosphorus Sulfur. 18:1983;483.
15. Quimby O.T., Prentice J.B., Nicholson D.A. J. Org. Chem. 32:1967;4111-4114.
16. McKenna C.E., Khawli L.A., Levy J.N., Harutunian V., Ye T.-G., Bapat A., Starnes M.C., Cheng Y.-C. Martin J.C. Nucleotide Analogues as Antiviral Agents. ACS Symposium Series. vol. 401:1989;1-16 American Chemical Society, Washington, DC.
17. Talanian R.V., Brown N.C., McKenna C.E., Ye T.G., Levy J.N., Wright G.E. Biochemistry. 28:1989;8270-8274.
18. Peng Z.-Y., Mansour J.M., Araujo F., Ju J.-Y., McKenna C.E., Mansour T.E. Biochem. Pharm. 49:1995;105-113.
19. Wright G.E., Hubscher U., Khan N., Focher F., Verri A. FEBS Lett. 341:1994;128-134.
20. Khan N.N., Reha-Krantz L.J., Wright G.E. Nucleic Acids Res. 22:1994;232-240.
21. Other workers have reported difficulties with this approach, see following reference.
22. ′ -triphosphate. Both COMB analogues were potent, competitive inhibitors of human DNA pol α. Yanachkov I.B., Stattel J.M., Wright G.E. J. Chem. Soc. Perkin Trans. 1:2001;3080-3089.
23. McKenna C.E., Kashemirov B.A., Li Z.-M. Phosphorus, Sulfur Silicon Relat. Elem. 144-146:1999;313-316.
24. McKenna C.E., Kashemirov B.A. Majoral J.-P. New Aspects of Phosphorus Chemistry I. Topics Phos. Chem. 220:2002;201-238 Springer Verlag, Berlin.
25. Bonaz-Krause P.I., Kashemirov B.A., McKenna C.E. Phosphorus Sulfur Silicon Relat. Elem. 117:2002;2271-2272.
26. Balzarini J., Haller-Meier F., De Clercq E., Meier C. Antiviral Chem. Chemother. 12:2001;301-306.
27. Ray A.S., Yang Z., Shi J., Hobbs A., Schinazi R.F., Chu C.K., Anderson K.S. Biochemistry. 41:2002;5150-5162.
28. Parang K., Wiebe L.I., Knaus E.E. Curr. Med. Chem. 7:2000;995-1039.
29. Ohrui H., Mitsuya H. Curr. Drug Targets: Infect. Disord. 1:2001;1-10.
30. Debyser Z., De Clercq E. Riv. Immunol. Immunofarmacol. 16:1996;48-52.
31. Vrang L., Bazin H., Remaud G., Chattopadhyaya J., Oberg B. Antiviral Res. 7:1987;139-149.
32. Schneider B., Sarfati R., Deville-Bonne D., Veron M. J. Bioenerg. Biomembr. 32:2000;317-324.
33. Kedar P.S., Abbotts J., Kovacs T., Lesiak K., Torrence P., Wilson S.H. Biochemistry. 29:1990;3603-3611.
34. Girard P.-M., Pegram P.S., Diquet B., Anderson R., Raffi F., Tubiana R., Sereni D., Boerner D. J. Acquired Immune Deficiency Syndromes. 23:2000;227-235.
35. J.-Y. Ju, Ph.D. Thesis, University of Southern California, (1994).
36. Khare A.B., McKenna C.E. Synthesis. 1991;405-406.
37. McKenna C.E., Khawli L.A., Ahmad W.-Y., Phuong P., Bongartz J.-P. Phosphorus Sulfur. 37:1988;1-12.
38. Goldstein J.A., McKenna C., Westheimer F.H. J. Am. Chem. Soc. 98:1976;7327-7332.
39. For a photochemistry study of an unsymmetrical dialkyl (diazomethylene)bisphosphonate, see: Bartlett P.A., Carruthers N.I., Winter B.M., Long K.P. J. Org. Chem. 47:1982;1284-1291.
40. C.N. Roze, B.A. Kashemirov, C.E. McKenna, in preparation.
41. Campagne J.-M., Coste J., Jouin P. J. Org. Chem. 60:1995;5214-5223.
42. Campbell D.A. J. Org. Chem. 57:1992;6331-6335.
43. Campbell D.A., Bermak J.C. J. Org. Chem. 59:1994;658-660.
44. McKenna C.E., Higa M.T., Cheung N.H., McKenna M.C. Tetrahedron Lett. 1977;155-158.
45. McKenna C.E., Schmidhauser J. J. Chem. Soc. Chem. Commun. 1979;739.
46. McKenna C.E., Levy J.N. J. Chem. Soc. Chem. Commun. 1989;246-247.
47. C.E. McKenna, B.A. Kashemirov, USA Patent 6,147,245 (2000).
48. Rasanen J.P., Pohjala E., Nikander H., Pakkanen T.A. J. Phys. Chem. 100:1996;8230-8239.
49. Rasanen J.P., Pohjala E., Pakkanen T.A. J. Chem. Soc. Perkin Trans. 2:1996;39-47.
50. Rasanen J.P., Pohjala E., Pakkanen T.A. J. Chem. Soc. Perkin Trans. 2:1994;2485-2490.
51. Rasanen J.P., Pohjala E., Nikander H., Pakkanen T.A. J. Phys. Chem. A. 101:1997;5196-5204.